TherapeuticsMD (TXMD) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Powered by 
Analysis
TherapeuticsMD (TXMD) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 17.76% |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -38.91% |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -63.37% |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 93.04% |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | -25.59% |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 23.99% |
| Jun 30, 2025 | 37.70% |
| Sep 30, 2024 | -326.40% |
| Jun 30, 2024 | -915.41% |
| Mar 31, 2023 | -4,200.62% |
| Mar 31, 2022 | 56.68% |
| Dec 31, 2021 | -2.75% |
| Sep 30, 2021 | -63.29% |
| Jun 30, 2021 | 27.74% |
| Mar 31, 2021 | 64.80% |
| Dec 31, 2020 | 41.99% |
| Sep 30, 2020 | 32.74% |
| Jun 30, 2020 | 37.99% |
| Mar 31, 2020 | 55.40% |
| Dec 31, 2019 | 56.96% |
| Sep 30, 2019 | 71.11% |
| Jun 30, 2019 | 83.37% |
| Mar 31, 2013 | 84.93% |
| Dec 31, 2012 | 92.92% |
| Sep 30, 2012 | 47.03% |